chrisvoncsefalvay/vaers-outcomes huggingface dataset:
On 03/16/2023, I had chest pain and it continued and hurt through to my back and spread up to my shoulder and down my arm. I called an ambulance, and I was taken to ER. I was given blood pressure medication; it was very high. I had a chest x-ray, blood work and I was kept over night and given a ultrasound and a stress test, a EKG and monitored my vitals. The decided it was not a heart attack. I was sent home the next day by 4pm. I feel under the weather now and I am really tired and achy. It?s a general discomfort. I go see the doctor next week.
This spontaneous report as received from a pharmacist refers to a 65 year old female patient. the patients medical history and drug reactions was unspecified. On 10-MAY-2013, the patient was vaccinated with ZOSTAVAX lot # H020845, expiry date 20-FEB-2014, subcutaneous. On 12-MAY-2013, 3 days after onset of therapy the patient experienced redness 'about a half dollar size', itching, swelling and a lump. The outcome of a lump, itching, swelling and redness 'about a half dollar size' was reported as recovering/resolving. The reporter did not assess the relationship between the events and ZOSTAVAX. Additional information has been requested.
on 1/26/21 Found laying on Bathroom Floor in Bedroom Apt. Complaint of Right Shoulder paiN bleeding (unknown origin) then discovered origin HANd/FiNgers. (Head on Floor towARds WALL) SeNT TO ER 1/26/21, Admitted 1/26/21 Diagnosis: AoRtic STENOSIS
Hot, swollen, sl tender - Lt deltoid area. 5cm x 6cm area of erythema - no fever, Rx - Benadryl and Duricef.
My arm began itching very soon after getting vaccine but grew worse by the evening and next day when there was a red, hard and swollen, painful and extremely itchy area.  It lasted for about 5 days in the extremely itchy state and was still somewhat itchy at 7 days and then faded.  (It was painful as well, but the itchiness was the worse part). I took Advil and saw online that this was a normal reaction some people get and so I did not report it to the doctor.
Sharp pain in head, right eye area every 3 to 5 minutes; This is a spontaneous report from a contactable consumer (reported for herself). A (58 unit: unknown) non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection),  via an unspecified route of administration, administered in right arm on 03Mar2021 at 13:15 (Batch/Lot number was not reported) as 1st dose, single for Covid-19 immunisation. Patient's medical history and concomitant medication were reported as none. No known allergies were reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive any other medication in two weeks prior to the COVID vaccine. The patient did not test COVID-19 positive prior to vaccination. The patient had not been tested for COVID-19 since the vaccination. On 05Mar2021 at 03:45, the patient experienced sharp pain in head, right eye area every 3 to 5 minutes. No treatment was received for the event. The outcome for the event was not recovered.  No follow-up attempts are possible; Information about lot/batch number cannot be obtained.
10-9-15 after vaccine leaving office could taste medicine quickly went away. From about 10-10-15 to 10-13-15 experiencing sharp, stinging sensation in chest felt like electric shocks. 10-17-15 Emergency Room visit. AV nodal re-entry tachycardia. Week of Oct. 19, 2015 discomfort both leg joints. 10-23-15 Emergency Room palpitations. Also during the time after 10-9-15 periods of wheezing and bad indigestion with belching having to sleep with head raised from 10-16-15 until 10-22-15.
2 days post vax, the pt developed vesicular lesions. (10 on upper trunk.)
p/vax pt devel a gen rash all over body w/fewer than 20 red pimples,some w/fluid filled centers & some scabbing over;pt also exp a fever on the fist day of rash which resolved;
Information has been received from a Medical Assistant referring to a patient of unknown age and gender. Information regarding medical history and concurrent condition was not provided. On an unknown date the patient was vaccinated with a dose of PNEUMOVAX 23 (dose, dose number, lot #, application site and route were not reported). Concomitant medication was not reported. On an unknown date the patient experienced and adverse event. It was not confirmed what the specific adverse event that the patient experienced. The outcome of event was unknown. The causality was not reported. Additional information is not expected because the reporter declined to complete the report because she did not have authorization from the physician in the office and there is no patient or physician's contact details.
Patient with mild gastroenteritis including mild abdominal pain and diarrhea; received influenza vaccine 10/15. Next day, patient experienced severe abdominal pain/tenderness. Exploratory laparoscopy revealed no perforation or significant inflammation of appendix. Post laparoscopy, patient's pain resolved. Per 60 day follow up: Pt has not recovered. Pt still with ongoing abdominal pain, bloody urine, fatigue. No other additional comments.
There is no known adverse reactions at this time. Patient was given 0.2ml of diluted (1.3ml diluent) Pfizer RTU instead of the Pfizer pediatric 0.2ml.
tingling in lips; tingling in hands; felt faint; felt nauseas; This spontaneous case was reported by an other health care professional and describes the occurrence of PARAESTHESIA ORAL (tingling in lips), PARAESTHESIA (tingling in hands), DIZZINESS (felt faint) and NAUSEA (felt nauseas) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 060H21A) for COVID-19 vaccination.     Previously administered products included for Product used for unknown indication: Pfizer (Pfizer 1st dose) on 05-Feb-2021 and Pfizer (Pfizer 2nd dose) on 26-Feb-2021. Past adverse reactions to the above products included No adverse event with Pfizer and Pfizer.    On 27-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 ml. On 27-Dec-2021, the patient experienced PARAESTHESIA ORAL (tingling in lips), PARAESTHESIA (tingling in hands), DIZZINESS (felt faint) and NAUSEA (felt nauseas). On 27-Dec-2021, PARAESTHESIA ORAL (tingling in lips), PARAESTHESIA (tingling in hands), DIZZINESS (felt faint) and NAUSEA (felt nauseas) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 27-Dec-2021, Blood glucose: low (Low) low. On 27-Dec-2021, Heart rate: normal (normal) normal. On 27-Dec-2021, Respiratory rate: normal (normal) normal.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant Products were reported. Treatment medication include Coke- For sugar level increase.  Patient has no pre-existing conditions.  Patient had the events within  15 minutes of getting the booster. It was reported that the symptoms resolved soon after and the  total time of this event was 11:30 AM  to 12:20 PM.
Pt reported AE to pharmacy 10/13/16. Some time later in the afternoon her tongue began to swell. She went to Urgent Care sometime after 5:00PM, was given Benadryl and began to feel better. Patient reported she felt fine the next day.
I received my vaccine on Sunday, work up Monday with sore arm which I expected. Monday night around 9pm I had a fever 101.3, my normal pain lever increased bad, and my balance of worse than normal, to walk 20 yards I had to stop at least 5 times because my back was hurting so bad. The next day, I woke up with normal fever but there was redness on the injection site a little larger than a silver dollar, around 8 my fever went up to 100. The next night, Wednesday night my fever was at 99.6, the next day my temp was normal and continued to be the rest of the time. The redness on my arm started fading and has continued to fade but I can still see where it is.
This spontaneous report as received from a licensed practical nurse refers to a 62 years old male patient with hypercholesterolemia, allergic rhinitis and no drug reactions/allergies. The patient was vaccinated subcutaneously with a dose of 0.65 ml ZOSTAVAX (lot number reported as H011052, expiration date 05-SEP-2013) on 28-OCT-2012. Concomitant medications included amitriptyline, atorvastatin and fluticasone nasal spray. The patient developed shingles, started on 13-NOV-2012. He was examined on 16-NOV-2012 by a physician who confirmed that he had an outbreak of vesicles on his right lower back. The patient was also experiencing peripheral neuropathy. The patient consulted the physician for medical attention. No laboratory diagnostics studies were performed. Acyclovir, acetaminophen, PERCOCET and hydroxyzine were given for treatment. The outcome of the events was reported as not recovered/not resolved. Additional information has been requested.
2 hours after injection patient experience hives on upper torso, and mid and low back. Hives started spreading on the neck. Patient had NO shortness of breath. Itching on left knee. Patient given oral benadryl and then 30 minutes later received 20mg of pepcid. Patient cleared of hives by that night but reoccurred Saturday afternoon with a mild case of  hives on the neck. Patient took dose of benadryl. Patient does have a few small areas of redness noted on right arm.
Seriousness criteria other medically significant. Other manufacturers reference number: A0636909A. Initial report received from another manufacturer on 26 February 2007. The information was provided to the other company by a health care professional. A patient of unspecified age or gender received the following injection on an unspecified date, DTaP (manufacturer unspecified), Ipol, and MMR II for prophylaxis. The patient's medical history and concurrent medications were not provided. An unspecified time after vaccination, the patient experienced anaphylaxis that required an emergency room visit. The reporting pharmacist considered the event to be clinically significant (or requiring intervention). At the time of this report, the outcome of the event was unspecified. The reporter of this case is the same as for case 2007-00549, which involved a case of anaphylaxis following the administration of DTaP, Ipol, and MMR.
testing positive for COVID after receiving vaccine; testing positive for COVID after receiving vaccine; This is a spontaneous report from a contactable pharmacist reported similar events for 14 patients. This is 10th of 14th reports.   An elderly patient (more than 65 years old) of an unspecified gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 13Jan2021 at single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. The patient experienced testing positive for COVID after receiving vaccine on 21Jan2021 with outcome of unknown. It was reported that 8 patients and 6 workers at a long term care facility were vaccinated on 13Jan2021 and reported testing positive for COVID on 21Jan2021. Since they were testing positive, physician wanted to administer bamlanirimab. The event resulted in doctor or other healthcare professional office/clinic visit. Outcome of the events was unknown.  Information about lot/batch number has been requested.; Sender's Comments: Based on the information available, a possible contributory role of the suspect BNT162B2 cannot be excluded for the reported testing positive for COVID based on the known safety profile. However the short duration of 8 days since the vaccine first dose is given it is unlikely patient would have fully developed immunity.,Linked Report(s) : US-PFIZER INC-2021063794 as reporter/drug/event, different patient.
Patient woke up with a red circle near the site of injection, it was tender to the touch, and hot and swollen. Patient states it was sore only ,and no shortness of breath.
Patient reports she had shoulder pain for several weeks and had difficulty using and raising her arm, patient did not report this event until Feb 14, 2023
Pale, decreased muscle tone, weak cry, decreased activity. Note-not reported with 5/01/08.
I received my COVID Vaccine Johnson & Johnson on April 5, 2021 about 3:45 p.m at Walgreens location listed above.  Immediate dizziness and pain on my left arm after receiving vaccine.  Next day woke up sick as if I had the flu. Third day I was ok but I have numbness on the left side of my body and felt very nauseous. I have been taking Dramamine to help. I can feel it from my head to my toes as far as the numbness is concern. The left side of my face is still numb. I have been very lightheaded and on Thursday 8, 2021 I had lunch with co workers and felt like fainting. Today is April 13, 2021 I am still lightheaded, and my face and left side of my body still numb and shaky. I feel is has been affecting my thinking.  I have not gone to ER, been tolerating it with Dramamine and rest.
My doctor said I should fill this out even though my reaction was not negative. After receiving the J&J shot I experienced a huge burst of energy that lasted 24 hours. I cleaned my house, made meals for the week, got on my treadmill at 4am. Did not sleep for 24 hours. It was not unpleasant. I did not experience any other side effects or flu symptoms. Hunting around on the internet I found a few other people with similar immune system problems who had a similar reaction. Other than that anecdotal evidence I have no idea why this happened. It was unexpected but pleasant
I am having neck pain and left arm pain.  I would say that the arm pain may be muscular.  I have been taking  ibuprofen and tylenol fo the past few days.  I went to the Chiropractor and had temporary relief of the neck pain.  It lasted for maybe 10 minutes it is hard to turn my head to the left.  I am just letting you know about the reaction.    The other thing is that the injection area the first day was very itchy I know better than to scratch it.  It becomes very itchy on and off yesterday and today.  These are probably not what you want for adverse side effects but I am letting you know that this is the case with me.
Have had increase in Tinnitus.  Have had partial loss of hearing in left ear, across all frequencies, and particularly at low frequencies. I test my hearing at home.  Have had hearing loss in both ears from 2013 thru 2017 but that resolved in 2018 and 2018 thru now hearing has been excellent.
Right after taking the first po dose of VIVOTIF, patient had swelling of her throat and the difficulty breathing - lasted 36 hrs; no hives or pruritis; she presented after sx gone.
On going nausea, dizziness, no energy , muscle cramps , and winded easily
Fever thru 5/25/2000, rash petichial  and purpuric. Slight puffiness of hands and feet. No altered mental status. Rash worse on extremities, some on face and trunk.
On the day of taking the vaccines had joint pains all over mainly involving the arms but they subsided. On the next day noticed redness and pain in the left eye. On 1/6/21 noticed diminished  vision and blurriness in the left eye. Called opthalmology  ED and was seen the next day on 1/7/2021 morning .  Was diagnosed with left uveitis. I was seen by the on call doctor.  There are many doctors involved in my care. My previous episodes of uveitis have been mostly in the right eye and the vision was not affected,  The doctors involved in my care are not sure if this was just a coincidence, was an exacerbation of the preexisting pathology or was something new.  I have asked to put the eye drops every hourly but the vision has not completely improved. I don't use the eye drops in the night and when I get up in the morning it is still very hard to read.  It is an unusual episode of uveitis as typically my left eye is not involved and I have never had this much diminished vision , I am supposed to put the drops every one hourly until 1/11/2021. I have informed my PCP, Rheumatologist, regular eye doctor.  I will inform my ID doctor Dr .
Sweating; Headaches; Body aches; Nausea; 104°f fever; Chills; Joint pain; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (Sweating), HEADACHE (Headaches), MYALGIA (Body aches), NAUSEA (Nausea) and PYREXIA (104°f fever) in a 35-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included ESCITALOPRAM OXALATE (LEXAPRO) for an unknown indication.   On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 21-Apr-2021, the patient experienced HYPERHIDROSIS (Sweating), HEADACHE (Headaches), MYALGIA (Body aches), NAUSEA (Nausea), PYREXIA (104°f fever), CHILLS (Chills) and ARTHRALGIA (Joint pain). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, HYPERHIDROSIS (Sweating), HEADACHE (Headaches), MYALGIA (Body aches), NAUSEA (Nausea), PYREXIA (104°f fever), CHILLS (Chills) and ARTHRALGIA (Joint pain) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 21-Apr-2021, Body temperature: 104 (High) 104 F.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Stomach medication was used as a concomitant medication. Action taken with the product mRNA-1273 was not Applicable.
reported rash on arm-- across entire back, itchy lasting 1-2 wks (not seen by provider) and worsening of asthma symptoms
Temperature excursion/beyond use date excursion; Temperature excursion/beyond use date excursion; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Temperature excursion/beyond use date excursion) and EXPIRED PRODUCT ADMINISTERED (Temperature excursion/beyond use date excursion) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 067H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Jan-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Temperature excursion/beyond use date excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Temperature excursion/beyond use date excursion). On 20-Jan-2022, EXPIRED PRODUCT ADMINISTERED (Temperature excursion/beyond use date excursion) had resolved. At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Temperature excursion/beyond use date excursion) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication information was not provided by the reporter.  Treatment information was not provided by the reporter.
feels like he is coming down with something; throat is itchy and feels like it's stripped; feels tired; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (feels like he is coming down with something), THROAT IRRITATION (throat is itchy and feels like it's stripped) and FATIGUE (feels tired) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-May-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-May-2021, the patient experienced FEELING ABNORMAL (feels like he is coming down with something), THROAT IRRITATION (throat is itchy and feels like it's stripped) and FATIGUE (feels tired). At the time of the report, FEELING ABNORMAL (feels like he is coming down with something), THROAT IRRITATION (throat is itchy and feels like it's stripped) and FATIGUE (feels tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient  on call stated that he is now feeling fine and his 2nd dose is scheduled for June 24th, 2021 and is going for a surgery on June 16th  No concomitant mediations were reported No treatment mediations were reported   Most recent FOLLOW-UP information incorporated above includes: On 09-Jun-2021: TCR: 2nd shot status. gave consent for another FU
This case was reported by a pharmacist via call center representative and described the occurrence of insomnia in a elderly male patient who received SHINGRIX (batch number B5EK2, expiry date 28th April 2020). On an unknown date, the patient received the 1st dose of SHINGRIX. On an unknown date, less than a day after receiving SHINGRIX, the patient experienced insomnia, injection site pain, injection site erythema and injection site discomfort. On an unknown date, the outcome of the insomnia, injection site pain, injection site erythema and injection site discomfort were unknown. The reporter considered the insomnia to be related to SHINGRIX. The reporter considered the injection site pain, injection erythema and injection site discomfort to be almost certainly related to SHINGRIX. The additional details were provided as follows: The age at vaccination was not reported. The patient experienced insomnia the night after vaccination with SHINGRIX, he also experienced injection site redness and discomfort. The health care professional called to report the insomnia. The patient felt it was related. The health care professional had not spoken to the patient since the initial report and was unsure if symptoms had resolved.
It was reported that a 40 year old female patient was administered a Fluzone SV '01-'02 vaccination, Lot U0862AA in 11/01 at work. Later that evening she reported a burning swollen arm and developed a rash. She reports using Benadryl, which alleviated it somewhat.  Nurse reported she has allergies to sulfur penicillin and milk products. When the nurse saw her, she stated that the rash was gone and all she observed was little scratch marks where patients was probably scratching She gave her cortisone cream.
8/12/13 sore arm, couldn't sleep, HA, vomiting. 8/13/13 vomiting, nausea, HA, unsteady feet.
nausea; stomach pain; diarrhea; body aches; headache; This is a spontaneous report from a contactable consumer (nurse).    A 75-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number and Expiration date was not reported), dose 1 via an unspecified route of administration on 28Jan2021 as dose 1, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On 29Jan2021 02:00 She reports waking up 8 hours later at 2am the patient experienced nausea, stomach pain, diarrhea, body aches and headache. Patient wanted to know After the second dose, do people have more or less side effects than the first dose. The patient received treatment of a tylenol and gasx and went back to bed. At the time of reporting, the outcome of the events were unknown.  Information on the lot/batch number has been requested.  Follow-up attempts are completed. No further information is expected.
This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. No information regarding the patient's pertinent medical history, concomitant medication and drug reactions or allergies was reported. On an unknown date, the patient was vaccinated with a dose of improperly stored ROTATEQ, 2 ml, once, orally, lot # L000568, expiration date 10-JUL-2016. No adverse effects were reported. Additional information has been requested.